Surgical outcomes of lenvatinib treatment followed by liver resection for large advanced hepatocellular carcinoma.

Authors

Koji Imai (ORCID: https://orcid.org/0000-0001-9318-1450)
Hideki Yokoo (ORCID: https://orcid.org/0000-0002-6203-8528)
Hiroyuki Takahashi (ORCID: https://orcid.org/0000-0001-7003-5151)
Shoichiro Mizukami (ORCID: https://orcid.org/0009-0001-9182-8369)

Institutions

Asahikawa Medical University (JP)

Publication Details

Journal: Journal of Clinical Oncology
Published: 2025-05-28
DOI: https://doi.org/10.1200/jco.2025.43.16_suppl.e16309
Citations: 1
Primary Topic: Hepatocellular Carcinoma Treatment and Prognosis
Type: article
Field-Weighted Citation Impact: 1.32

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Surgical outcomes of lenvatinib treatment followed by liver resection for large advanced hepatocellular carcinoma.

Koji Imai, Hideki Yokoo, Hiroyuki Takahashi, Shoichiro Mizukami

May 28, 2025

1 citations

Journal of Clinical Oncology

Hepatocellular Carcinoma Treatment and Prognosis

1.32

article

Surgical outcomes of lenvatinib treatment followed by liver resection for large advanced hepatocellular carcinoma.

Koji Imai, Hideki Yokoo, Hiroyuki Takahashi, Shoichiro Mizukami

May 28, 2025article en

1 citations

Abstract

No abstract available for this paper.

Journal of Clinical OncologyVol. 43(16_suppl)

Asahikawa Medical University (JP)

Openalex Percentile: Top 20%

Hepatocellular Carcinoma Treatment and Prognosis

1.32

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Surgical outcomes of lenvatinib treatment followed by liver resection for large advanced hepatocellular carcinoma. — Koji Imai, Hideki Yokoo, et al. · Journal of Clinical Oncology (2025) | TGRS Research Map | TGRS